Online HCP community allows HCPs and researchers access to the latest breakthroughs in medicine and life sciences research.
H1, has launched H1 Connect,1 the former Faculty Opinions, which it acquired in February 2022.2 Users across Life Sciences, Academic Medical Institutions, Research organizations and more access insights from H1 Connect to drive their respective fields forward.
The re-branded initiative includes the expansion of clinical trial and medical research evaluations by leading experts, as well as a bolstered community, to address the following pain points for HCPs:
With input from global Key Opinion Leaders (KOLs), H1 Connect is intended to provide HCPs with quick-to-read insights and commentary; knowledge facilitation and exchange; and collaboration among the global healthcare community.
References:
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.